NCT02510599View on ClinicalTrials.gov

Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

January 27, 2017

Study Completion Date

February 28, 2017

Conditions
Nonalcoholic Steatohepatitis
Interventions
DRUG

solithromycin

Trial Locations (1)

44106

Case Western University Hospitals, Cleveland

Sponsors
All Listed Sponsors
lead

Melinta Therapeutics, Inc.

INDUSTRY